Clinical Trials Directory

Trials / Completed

CompletedNCT03046849

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer Patients Meeting Chinese Lynch Syndrome Criteria: An Open-label and Multi-center Study.

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out the proportion of patients diagnosed with Lynch syndrome in colorectal cacner patients meeting Chinese Lynch syndrome criteria. Besides, this study is aimed to analyze the clinical characteristics and germline mutation of Lynch syndrome in Chinese population.

Detailed description

1. Detect germline mutation (by next-generation squencing) in probands. 2. Verify the germline mutation in blood relatives whose proband has known germline mutation(s). 3. Analyze the test data with clinical and family information. Diagnose Lynch syndrome in the included population. 4. Analyze the clinical characteristics and germline mutation of Lynch syndrome in Chinese population.

Conditions

Interventions

TypeNameDescription
OTHERnext-generation sequencingUse next-generation sequencing to test germline mutation.

Timeline

Start date
2017-03-08
Primary completion
2019-02-26
Completion
2019-02-26
First posted
2017-02-08
Last updated
2021-08-11

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03046849. Inclusion in this directory is not an endorsement.

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria (NCT03046849) · Clinical Trials Directory